Back to search

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

Data up to Jan 2025

Published1996
Citations1,906
References25

Total Citations Per Year

Abstract

References (25)

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 • 6,495 citations

Clinical staging of chronic lymphocytic leukemia

1975 • 2,706 citations

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

1995 • 749 citations

bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia

1993 • 660 citations

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1989 • 466 citations

A clinical staging system for chronic lymphocytic leukemia.Prognostic significance

1977 • 410 citations

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression

1993 • 372 citations

Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases

1984 • 325 citations

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]

1993 • 292 citations

HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic Leukemia

1996 • 256 citations

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

1991 • 255 citations

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

1993 • 244 citations

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.

1994 • 195 citations

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]

1992 • 176 citations

Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia

1993 • 168 citations

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.

1993 • 147 citations

Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses

1995 • 142 citations

Evidence for a new tumour suppressor locus (DBM) in human B–cell neoplasia telomeric to the retinoblastoma gene

1993 • 135 citations

High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics

1993 • 127 citations

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

1993 • 114 citations

True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases [see comments]

1995 • 106 citations

Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.

1994 • 98 citations

Progression and survival studies in early chronic lymphocytic leukemia

1991 • 81 citations

Manual of oncologic therapeutics

1991 • 67 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic… (1996) – Blood | Metascience Observatory Explorer